Guanosine 5′-[β,γ-imido]triphosphate trisodium salt hydrate
SIGMA/G0635 - ≥85% (HPLC), powder
Synonym: β:γ-Imidoguanosine 5′-triphosphate trisodium salt hydrate; 5′-Guanylyl-imidodiphosphate trisodium salt hydrate; GMP-PNP; Gpp(NH)p
CAS Number: 148892-91-5
Empirical Formula (Hill Notation): C10H14N6Na3O13P3 · xH2O
Molecular Weight: 588.14 (anhydrous basis)
MDL Number: MFCD00084770
Linear Formula: C10H14N6Na3O13P3 · xH2O
Product Type: Chemical
| assay | ≥85% (HPLC) |
| biological source | synthetic (organic) |
| color | white |
| form | powder |
| InChI | 1S/C10H17N6O13P3.3Na/c11- |
| InChI key | QGJNRMUNXAROIT-CYCLDIHTSA |
| Quality Level | 200 ![]() |
300 ![]() |
|
| shipped in | dry ice |
| SMILES string | [Na+].[Na+].[Na+].Nc1nc(O |
| solubility | H2O: 50 mg/mL |
| storage temp. | −70°C |
| Application: | Guanosine 5′-[β,γ-imido]triphosphat |
| Application: | Non-hydrolyzable analog of GTP; the preferred GTP analog to activate ADP-ribosylation factor. |
| Biochem/physiol Actions: | Guanosine 5′-[ß,γ-imido]triphosphat |
| General description: | Guanosine 5′-[β,γ-imido]triphosphat |
| Packaging: | 25, 100 mg in poly bottle |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥85% (HPLC) |
| Storage Temp. | −70°C |
| UNSPSC | 41106305 |


